Telemedicine consultation in India grew three times since the beginning of the COVID-19 pandemic began, a survey revealed.
The survey conducted by DrOnA Health in collaboration with Mankind Pharma revealed that 60 per cent of respondents reported to be highly satisfied with telemedicine consultation and 54 per cent expressed willingness to continue it in future too.
The survey polled over 3000+ respondents across genders and age groups in over 250+ cities.
The results show that telemedicine is here to stay and will become an integral part of Indian healthcare.
The perceived risk of getting infected at a clinic during COVID-19 is a key reason for patients opting for online consultation, which is safer, convenient and comparatively more economical.
The survey further shows that the patients adopt their doctors’ preferred telemedicine platform which is designed as per telemedicine guidelines.
Around 70 per cent of users do online consult with known doctors while nearly 60 per cent use it for a follow-up consultation.
The survey also showed a rise in telemedicine in the eastern part of country across Bihar, Jharkhand and West Bengal.
“Telemedicine is well established in other countries but COVID-19 pandemic triggered interest in our country with patients adopting this technology quickly,” said Mankind Pharma CEO Rajeev Juneja.
“This simple interaction not only offers convenience but provides an excellent solution to patients residing in remote areas by providing them with quality healthcare solution,” he added.
“Our survey has clearly shown that patients in India are proactively looking for telemedicine solutions and doctors who are adopting it are hugely benefiting,” he further said.
“We are confident that the services that DrOnApp has brought in this segment will write a new episode in the path of telemedicine adoption in India,” Juneja said.
DrOnA health is a dedicated doctor centric teleconsultation platform with over 10,000 Doctors on it.